Abstract:Backgrounds: The kidney is an easily affected organ with sepsis which is a main underlying cause of acute kidney injury (AKI). Histone-modifying lysine-specific demethylase 2B (KDM2B) is involved in numerous pathological processes, such as cell senescence and tumor development. However, the role of KDM2B in sepsis-induced AKI is unclear. Objects: To investigate the role of KDM2B on cell viability, inflammation and oxidative stress of sepsis-associated AKI, and the involved signaling pathways. Methods: An AKI model in vitro was established through lipopolysaccharide (LPS)-induction in HK-2 cells. Western blots were performed to evaluate the expression of KDM2B, cyclooxygenase 2 (COX2), inducible nitric oxide synthase (iNOS), p65, c-Jun and c-Fos, as well as p65 phosphorylation. Cell viability was measured using CCK-8 kit. ELISA was performed to analyze the production of layered double hydroxide (LDH), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-18, vascular cell adhesion molecule-1 (VCAM-1), superoxide dismutase (SOD), malondialdehyde (MDA), glutathione (GSH), and H2 O2 . The qPCR was used to evaluate the transcription level of TNF-α, IL-1β, IL-18, and VCAM-1. Results: KDM2B knockdown alleviated LPS-induced cytotoxicity, decreased LDH release, and improved cell viability. KDM2B knockdown reduced concentration of inflammation-related molecules including TNF-α, IL-1β, IL-18, and VCAM-1, and inhibited their transcription. Moreover, KDM2B knockdown promoted the quantity of SOD and GSH, while declined the production of MDA, H2 O2 , COX2, and iNOS. Further, KDM2B played a role in LPS-induced HK-2 cell injury by activating nuclear factor κB (NF-κB) and activator protein 1 (AP-1) pathways. Conclusion: KDM2B knockdown reduced cytotoxicity, inflammation and oxidative stress in LPS-induced AKI via inhibiting NF-κB and AP-1 pathways, indicating KDM2B may be a promising therapeutic target for the treatment of sepsis-associated AKI.

HIPK2 C-terminal domain inhibits NF-κB signaling and renal inflammation in kidney injury

Tubular HIPK2 is a key contributor to renal fibrosis

Role of HIPK2 in Kidney Fibrosis

A Systems Approach Identifies HIPK2 As a Key Regulator of Kidney Fibrosis

HIPK2 phosphorylates HDAC3 for NF-κB acetylation to ameliorate colitis-associated colorectal carcinoma and sepsis

Virtual Screening, Molecular Dynamics, and Mechanism Study of Homeodomain-Interacting Protein Kinase 2 Inhibitor in Renal Fibroblasts

The Inhibitor Effect of RKIP on Inflammasome Activation and Inflammasome-Dependent Diseases

Hepatocyte Growth Factor Suppresses Proinflammatory Nf Kappa B Activation Through Gsk3 Beta Inactivation In Renal Tubular Epithelial Cells

HCK induces macrophage activation to promote renal inflammation and fibrosis via suppression of autophagy

Protein Kinase CK2α Catalytic Subunit Ameliorates Diabetic Renal Inflammatory Fibrosis Via NF-κB Signaling Pathway.

Targeting NK-1R attenuates renal fibrosis via modulating inflammatory responses and cell fate in chronic kidney disease

Identification of Selective Homeodomain Interacting Protein Kinase 2 Inhibitors, a Potential Treatment for Renal Fibrosis

Mkp2 Inhibits Tgf-Beta 1-Induced Epithelial-To-Mesenchymal Transition In Renal Tubular Epithelial Cells Through A Jnk-Dependent Pathway

Activation of HIF-1α C-terminal transactivation domain promotes tubulointerstitial fibrosis through hexokinase 2-mediated metabolic reprogramming

Knockdown of HIPK2 Attenuates Angiotensin II–Induced Cardiac Fibrosis in Cardiac Fibroblasts

KDM2B regulates inflammation and oxidative stress of sepsis via targeting NF-κB and AP-1 pathways

Endothelial Hif-2 Mediates Protection And Recovery From Ischemic Kidney Injury

Both partial inactivation as well as activation of NF-κB signaling lead to hypertension and chronic kidney disease

Conditional knockout of TGF-βRII /Smad2 signals protects against acute renal injury by alleviating cell necroptosis, apoptosis and inflammation

The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis

The Ubiquitination of CKIP-1 Mediated by Src Aggravates Diabetic Renal Fibrosis (original Article)